-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Provectus Biopharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2011 to Q1 2024.
- Provectus Biopharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $2.23K, a 0.05% increase year-over-year.
- Provectus Biopharmaceuticals, Inc. annual Depreciation for 2023 was $8.92K, a 18.1% decline from 2022.
- Provectus Biopharmaceuticals, Inc. annual Depreciation for 2022 was $10.9K, a 15.3% decline from 2021.
- Provectus Biopharmaceuticals, Inc. annual Depreciation for 2021 was $12.9K, a 5.98% decline from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)